A detailed history of Rothschild Investment Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Rothschild Investment Corp holds 14,891 shares of NVO stock, worth $1.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,891
Previous 7,350 102.6%
Holding current value
$1.6 Million
Previous $1.19 Million 13.88%
% of portfolio
0.11%
Previous 0.1%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $685,778 - $1.5 Million
7,541 Added 102.6%
14,891 $1.35 Million
Q2 2023

Jul 18, 2023

SELL
$155.98 - $172.65 $1.26 Million - $1.39 Million
-8,055 Reduced 52.29%
7,350 $1.19 Million
Q1 2023

Apr 24, 2023

SELL
$132.34 - $159.14 $158,808 - $190,967
-1,200 Reduced 7.23%
15,405 $2.45 Million
Q4 2022

Jan 19, 2023

SELL
$102.55 - $135.33 $322,519 - $425,612
-3,145 Reduced 15.92%
16,605 $2.25 Million
Q3 2022

Oct 21, 2022

SELL
$95.28 - $116.93 $50,498 - $61,972
-530 Reduced 2.61%
19,750 $1.97 Million
Q2 2022

Jul 12, 2022

BUY
$103.24 - $121.81 $216,287 - $255,191
2,095 Added 11.52%
20,280 $2.26 Million
Q1 2022

Apr 18, 2022

BUY
$93.1 - $112.54 $307,230 - $371,382
3,300 Added 22.17%
18,185 $2.02 Million
Q4 2021

Jan 24, 2022

BUY
$95.88 - $117.08 $154,175 - $188,264
1,608 Added 12.11%
14,885 $1.67 Million
Q3 2021

Oct 12, 2021

BUY
$84.42 - $106.62 $30,391 - $38,383
360 Added 2.79%
13,277 $1.28 Million
Q2 2021

Jul 19, 2021

BUY
$67.66 - $84.76 $170,638 - $213,764
2,522 Added 24.26%
12,917 $1.08 Million
Q1 2021

Apr 15, 2021

BUY
$67.06 - $75.82 $697,088 - $788,148
10,395 New
10,395 $701,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.